Journal of Genetic Engineering and Biotechnology

Table 5 Comparison between eNOS genotype in ESRD among clinical data

From: Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients

		eNOS genotype						One-way ANOVA
		4aa		4ab		4bb		One-way ANOVA
		Mean	SD	Mean	SD	Mean	SD	F	P
Hb Conc.		9.67	2.17	10.27	1.42	10.16	2.16	0.609	0.546
Duration of dialysis (months)		39.05	44.30	28.40	35.73	29.48	35.01	0.583	0.56
Ca Conc.		7.94	0.69	8.38	1.22	8.33	1.23	1.051	0.354
Phosphate		6.42	2.32	4.95	1.68	6.41	2.63	4.176	0.018
PTH		466.20	397.92	397.70	249.17	529.98	534.57	0.854	0.429
Creat Conc.		7.65	2.67	9.08	3.13	7.64	3.01	2.428	0.094
Bilirubin		0.72	0.16	0.48	0.17	0.69	0.18	15.595	<0.001
Albumin		4.01	0.33	3.79	0.44	3.79	0.46	1.962	0.146
SGPT		19.20	7.36	24.33	16.47	31.84	27.02	2.824	0.064
SGOT		21.55	5.79	32.10	17.06	32.92	26.10	2.251	0.111
FBS		109.40	55.48	110.93	54.26	140.84	76.28	2.636	0.077
		No	%	No	%	No	%	Chi-square test
HBsAg	Negative	20	100.00	30	100.00	50	100.00	NA	NA
HCV	Negative	18	90.00	21	70.00	35	70.00
HCV	Positive	2	10.00	9	30.00	15	30.00	3.326	0.190

Back to article page